Mechanistic basis of inflammation in Alzheimers Disease

NIH RePORTER · NIH · R21 · $184,680 · view on reporter.nih.gov ↗

Abstract

Abstract Alzheimer’s disease (AD) is a progressive inflammatory neurodegenerative disorder leading to debilitating cognitive dysfunction, and is still without cure or effective prevention options. Several studies demonstrated that low grade inflammation in the brain is associated with higher risk of AD. Patients with AD exhibit an overproduction of the pro-inflammatory cytokine interleukin-1 beta (IL-1β) in the cerebrospinal fluid and brain tissue. Importantly, exaggerated IL-1β levels robustly inhibit synaptic plasticity mechanisms critical for normal memory function. In this application we will determine the function of members of the canonical and non- canonical inflammasome in relation of AD.

Key facts

NIH application ID
10259772
Project number
5R21AG064899-02
Recipient
OHIO STATE UNIVERSITY
Principal Investigator
Amal O Amer
Activity code
R21
Funding institute
NIH
Fiscal year
2021
Award amount
$184,680
Award type
5
Project period
2020-09-15 → 2022-04-30